Paricalcitol NDC 55111-663

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-663Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0663Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-663-01	55111066301	100 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-663-01)Marketed from Jun 25, 2014
55111-663-05	55111066305	500 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-663-05)Marketed from Jun 25, 2014
55111-663-30	55111066330	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-663-30)Marketed from Jun 25, 2014
55111-663-81	55111066381	3 BLISTER PACK in 1 CARTON (55111-663-81) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (55111-663-79)Marketed from Jun 25, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Paricalcitol
Generic name (nonproprietary): paricalcitol
Active ingredients: Paricalcitol — 1 ug/1
Dosage form: Capsule, Liquid filled
Route: Oral
Labeler: Dr. Reddy's Laboratories Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091412
Marketing start: Jun 25, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Cholecalciferol (Chemical structure)
Identifiers: Product ID 55111-663_9cdba353-c828-7ee6-0fed-9eb342df7ffcSPL ID 9cdba353-c828-7ee6-0fed-9eb342df7ffcSPL set ID aa1a80e9-8778-a03e-5d53-d4b6a6363169RxCUI 577315, 577317, 577324UNII 6702D36OG5
Pharmacologic class: Vitamin D3 Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111066301 followed by a unit qualifier and the quantity

Package 55111-0663-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 27, 2017.

Indications (excerpt from the label)

Paricalcitol is a vitamin D analog indicated in adults for the prevention and treatment of secondary hyperparathyroidism associated with. · Chronic kidney disease (CKD) Stages 3 and 4 ( 1.1 ). · CKD Stage 5 in patients on hemodialysis or peritoneal dialysis ( 1.2 ). 1.1 Chronic Kidney Disease Stages 3 and 4 Paricalcitol capsules are indicated in adults for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4. Pediatric use information for patients 10 to 16 years of age is approved for AbbVie Inc.’s Zemplar (paricalcitol) capsules. However, due to AbbVie Inc.’s marketing exclusivity rights, this drug product is not labeled w…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091412

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091412
Product	Strength	Form · route	Labeler	Product NDC
Paricalcitol	Paricalcitol 2 ug/1	Capsule, Liquid filledOral	Dr. Reddy's Laboratories Limited	55111-664
Paricalcitol	Paricalcitol 4 ug/1	Capsule, Liquid filledOral	Dr. Reddy's Laboratories Limited	55111-665